We are live on ! Find out more
ZYNE

Zynerba Pharmaceuticals, Inc
ZYNE

Delisted

ZYNE was delisted on the 10th of October, 2023.

Back to rankings

58 hedge funds and large institutions have $21.6M invested in Zynerba Pharmaceuticals, Inc in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 13 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 13

33% more capital invested

Capital invested by funds: $16.2M → $21.6M (+$5.37M)

26% more call options, than puts

Call options by funds: $1.63M | Put options by funds: $1.29M

12% less funds holding

Funds holding: 66 → 58 (-8)

47% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 17

Holders
58
Holders Change
-8
Holders Change %
-12.12%
% of All Funds
1.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
20
Reduced
13
Closed
17
Calls
$1.63M
Puts
$1.29M
Net Calls
+$336K
Net Calls Change
+$179K

Top Buyers

Rank Fund Capital Flow
1
EMG
ETF Managers Group
New Jersey
+$3.51M
2
AI
AdvisorShares Investments
Maryland
+$976K
3
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
+$921K
4
Renaissance Technologies
Renaissance Technologies
New York
+$476K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$451K

Top Sellers

Rank Fund Capital Flow
1
PCM
Prentice Capital Management
Connecticut
-$1.29M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$374K
3
Walleye Capital
Walleye Capital
New York
-$171K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$154K
5
Group One Trading
Group One Trading
Illinois
-$127K
Name Holding Trade Value Shares
Change 		Change in
Stake
Qube Research & Technologies (QRT)
26
Qube Research & Technologies (QRT)
United Kingdom
$87K +$37.3K +9,810 +59%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$77K +$50.5K +13,288 +131%
AG
28
Algert Global
California
$69K -$115K -30,250 -59%
California Public Employees Retirement System
29
California Public Employees Retirement System
California
$60K – – –
PP
30
PDT Partners
New York
$59K +$68.1K +17,927 New
KWMG
31
King Wealth Management Group
Florida
$53K +$60.8K +16,000 New
Morgan Stanley
32
Morgan Stanley
New York
$47K -$8.96K -2,359 -14%
Commonwealth Equity Services
33
Commonwealth Equity Services
Massachusetts
$44K -$835 -220 -2%
AAA
34
Affinity Asset Advisors
New York
$44K +$50.4K +13,285 New
LPL Financial
35
LPL Financial
California
$43K +$6.56K +1,728 +15%
SFS
36
Sowell Financial Services
Arkansas
$42K +$47.5K +12,500 +15,625%
Osaic Holdings
37
Osaic Holdings
Arizona
$36K -$37.2K -9,800 -46%
Group One Trading
38
Group One Trading
Illinois
$26K -$127K -33,468 -81%
UBS Group
39
UBS Group
Switzerland
$23K +$5.63K +1,483 +26%
FCMT
40
Founders Capital Management (Texas)
Texas
$18K +$7.59K +2,000 New
ASN
41
Advisory Services Network
Georgia
$12K -$19.4K -5,100 -59%
CG
42
Cutler Group
California
$12K – – –
Wells Fargo
43
Wells Fargo
California
$8K +$3.15K +831 +51%
NFG
44
Next Financial Group
Texas
$6K – – –
Citigroup
45
Citigroup
New York
$3K – – –
PFO
46
Pathstone Family Office
New Jersey
$3K – – –
RWA
47
Ropes Wealth Advisors
Massachusetts
$3K – – –
FFA
48
Freedman Financial Associates
Massachusetts
$3K +$3.42K +900 New
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
$2K -$154K -40,608 -99%
IAIM
50
International Assets Investment Management
Florida
$2K +$2.37K +625 New
1
2
3

ZYNE Hedge Fund Activity: Q4 2020 in Review

58 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Zynerba Pharmaceuticals, Inc (ZYNE) for Q4 2020, worth a combined $21.6M — up 33% from $16.2M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of ZYNE and 9 opened new positions — a net loss of 8 holders — while 13 trimmed existing stakes and 20 added.

The largest buyer was ETF Managers Group, adding an estimated $3.51M. The largest seller was Prentice Capital Management, exiting entirely with an estimated $1.29M sold.

  • 58 institutional investors held Zynerba Pharmaceuticals, Inc (ZYNE) as of Q4 2020, down from 66 in Q3 2020.
  • Funds reported $21.6M of Zynerba Pharmaceuticals, Inc stock for Q4 2020, up 33% quarter-over-quarter.
  • 9 funds opened new Zynerba Pharmaceuticals, Inc positions in Q4 2020 and 17 closed out, a net change of -8 holders.
  • The largest Zynerba Pharmaceuticals, Inc buyer in Q4 2020 was ETF Managers Group, an estimated $3.51M added.
  • The largest Zynerba Pharmaceuticals, Inc seller in Q4 2020 was Prentice Capital Management, an estimated $1.29M sold.

Based on aggregated 13F filings for Q4 2020.